What Are the Advantages of Bispecific Monoclonal Antibodies?
The primary advantages of bsAbs include:
Enhanced Specificity: By targeting two different antigens, bsAbs can improve the specificity and selectivity of cancer treatment. Synergistic Effects: BsAbs can simultaneously engage multiple pathways, leading to synergistic anti-tumor effects. Reduced Resistance: Dual targeting can reduce the likelihood of cancer cells developing resistance to therapy. Versatility: BsAbs can be designed to target a wide range of antigens, making them versatile tools in cancer therapy.
